All comparisons
GILD vs MRNA
Gilead Sciences, Inc. vs Moderna, Inc.
Overview
GILDGilead Sciences, Inc.
Score A+Price
$130.28
Fair Value
$169.36
Upside
+30.0%
Convex Score
10/10
MRNAModerna, Inc.
Score D (Speculative)Price
$59.66
Fair Value
$32.39
Upside
-45.7%
Convex Score
1/10
Valuation
GILD
Bear$117.25
Base$194.46
Bull$314.57
Fair Value$169.36
MRNA
Bear$19.43
Base$32.39
Bull$45.35
Fair Value$32.39
Quality
GILD
Grade
A
Score
107/100
Classification
Compounder
Rating
Score A+
MRNA
Grade
D
Score
39/100
Classification
Compounder
Rating
Score D (Speculative)
Company Info
| GILD | MRNA | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| Classification | Compounder | Compounder |
Verdict
GILD has better risk/reward
GILD: Higher upside potentialGILD: Higher Convex ScoreGILD: Better quality grade